Rayan, A., Abdel-Kareem, S., Hasan, H., Zahran, A. M., & Gamal, D. A. (2020). Hypofractionated radiation therapy with temozolomide versus standard chemoradiation in patients with glioblastoma multiforme (GBM): A prospective, single institution experience. Rep Pract Oncol Radiother.
Chicago Style CitationRayan, Amal, Samya Abdel-Kareem, Huda Hasan, Asmaa M. Zahran, i Doaa A. Gamal. "Hypofractionated Radiation Therapy With Temozolomide Versus Standard Chemoradiation in Patients With Glioblastoma Multiforme (GBM): A Prospective, Single Institution Experience." Rep Pract Oncol Radiother 2020.
Cita MLARayan, Amal, et al. "Hypofractionated Radiation Therapy With Temozolomide Versus Standard Chemoradiation in Patients With Glioblastoma Multiforme (GBM): A Prospective, Single Institution Experience." Rep Pract Oncol Radiother 2020.